US drug approvals
5 approvals with a product on the US market
- Olanzapine ANDA211072 · approved 11 Jun 2025
- Leuprolide Acetate ANDA217957 · approved 17 Oct 2024
- Voriconazole ANDA211264 · approved 9 Mar 2023
- Desmopressin Acetate ANDA210223 · approved 17 Sep 2020
- Desmopressin Acetate ANDA210218 · approved 14 Feb 2020
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.